Hirokazu Kashiwagi
Overview
Explore the profile of Hirokazu Kashiwagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashiwagi H, Miura I, Terasawa N, Iwayama K, Furukawa Y, Kanenishi M
Int J Hematol
. 2025 Jan;
121(3):427.
PMID: 39888517
No abstract available.
2.
Kashiwagi H, Miura I, Terasawa N, Iwayama K, Furukawa Y, Kanenishi M
Int J Hematol
. 2024 Dec;
121(3):363-377.
PMID: 39668284
Recent trends in the treatment of primary immune thrombocytopenia (ITP) were investigated using a claims database that included data from 16,161 Japanese patients with ITP collected from April 2014 to...
3.
Kashiwagi H
Rinsho Ketsueki
. 2024 Oct;
65(9):1101-1105.
PMID: 39358266
Two thrombopoietin receptor agonists (eltrombopag and romiplostim), rituximab or splenectomy have been recommended for the treatment of glucocorticoid-resistant ITP in Japanese guidelines. In addition, the Syk inhibitor fostamatinib and FcRn...
4.
5.
Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J, et al.
Int J Hematol
. 2023 Nov;
119(1):1-13.
PMID: 37957517
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia due to accelerated platelet destruction and impaired platelet production. Diagnosis of ITP is still challenging because ITP has...
6.
Kashiwagi H
Rinsho Ketsueki
. 2023 Jun;
64(5):397-405.
PMID: 37271531
Increased and impaired platelet productions via immunological abnormalities are the main pathophysiological mechanisms of primary immune thrombocytopenia (ITP). Recent studies have revealed that platelet removal from circulation involves not only...
7.
Kiyokawa T, Mimura K, Nagamine K, Nakayama K, Horiuchi M, Morikawa T, et al.
Int J Hematol
. 2023 Feb;
118(1):146-150.
PMID: 36797397
Background: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is caused by anti-HPA alloantibody, and anti-HPA-4b is the most common cause in Japanese. Anti-HPA-5b is frequently detected in pregnant women, but it...
8.
Senda A, Saito H, Kusakabe S, Yoshida K, Shibata K, Kida S, et al.
Rinsho Ketsueki
. 2023 Feb;
64(1):35-41.
PMID: 36775305
Acquired hemophilia A (AHA) is a rare disease characteized by bleeding symptoms caused by decreased factor VIII activity due to the appearance of inhibitors to factor VIII triggered by malignancy...
9.
Kashiwagi H
Int J Hematol
. 2023 Jan;
117(3):314-315.
PMID: 36656456
Immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), and vaccine-induced immune thrombotic thrombocytopenia (VITT) all have "thrombocytopenia" in their name, and all but congenital TTP are caused by immune mechanisms, but...
10.
Kubo M, Sakai K, Hayakawa M, Kashiwagi H, Yagi H, Seki Y, et al.
J Thromb Haemost
. 2022 Mar;
20(7):1589-1598.
PMID: 35352474
Background: Patients with essential thrombocythemia (ET) often experience bleeding associated with acquired von Willebrand syndrome (AVWS) when the platelet count is markedly increased. Objective: We investigated whether von Willebrand factor...